Axogen, Inc. Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 5, 2025
ALACHUA, Fla. and TAMPA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the second quarter ended June 30, 2025.
Read more at globenewswire.com
